ARTICLE | Clinical News

Connaught Laboratories Inc. regulatory update

July 17, 1995 7:00 AM UTC

Connaught (Swiftwater, Penn.) filed for FDA approval of an additional indication for its Tripedia diphtheria, tetanus and acellular pertussis vaccine in infants two, four and six months old. The vaccine, which incorporates two pertussis antigens - PT and FHA - is approved for use in booster doses for children older than 15 months. ...